With the commercialization of Qvella technology for Positive Blood Culture (PBC) processing, healthcare facilities can now get results up to 24 hours faster than current methods
This recommendation is based on new data from two randomized controlled trials involving 3078 patients
The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the USFDA for an EV therapeutic
Key findings underscore the need for better control of glycemia, blood pressure and lipid parameters to prevent diabetes-related complications
He has extensive leadership experience across supply chain and has worked at companies such as Unilever, Flipkart, Colgate-Palmolive & Mondelez
Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses
The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise
The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes
U GRO Capital is a listed MSME lending fintech platform
Strive to empower public health with disinfection robotics solutions in post-pandemic era
Subscribe To Our Newsletter & Stay Updated
